BSD Medical Signs Distribution Agreement with Comed Medical Specialties for MicroThermX® Microwave Ablation Products
10 July 2014 - 11:20PM
Business Wire
BSD Medical Corporation (NASDAQ: BSDM) (Company or BSD)
(www.BSDMedical.com), a leading provider of medical systems that
utilize heat therapy to treat cancer, announced today that the
Company has signed an agreement with Comed Medical Specialties
(Comed) for the sales and distribution of the MicroThermX Microwave
Ablation (MicroThermX) line of products.
Comed Medical Specialties is the number one specialty medical
distributor in the Western United States. Comed has a thirty-year
history of selling innovative medical devices to the interventional
radiology market. Comed has well-established, key relationships
with department heads at interventional radiology institutions
throughout the West. Comed has 10 sales personnel specializing in
selling innovative surgical and interventional radiology
products.
Based in Salt Lake City, Utah, Comed has the rights to market
the MicroThermX line of products in Arizona, California, Colorado,
El Paso, Texas, Nevada, New Mexico, and Utah. Comed’s sales team
will work hand-in-hand with BSD sales management and BSD’s direct
sales representatives and clinical specialist in the West to
penetrate one of the largest target markets for MicroThermX
products in the United States.
“We are pleased to partner with a distributor of Comed’s caliber
in interventional radiology products, as this is another essential
step in presenting the advantages of the MicroThermX to opinion
leaders throughout the West,” said Brian Ferrand, BSD Vice
President of Domestic Sales. “Comed has long-established
relationships with key interventional radiologists and capital
equipment purchasers, which will increase sales of our products in
the Western United States.”
“The chance to distribute BSD’s MicrothermX product line is
exceptionally attractive to Comed,” said Mike Mahoney, Principal
with Comed. “Microwave ablation technology is in a rapidly growing
market sector for treating cancer and Comed sees a tremendous
opportunity to offer MicroThermX to its extensive base of
established customers.”
About the MicroThermX Microwave Ablation
System
The MicroThermX Microwave Ablation System is a compact, mobile,
state-of-the-art, proprietary system that includes a microwave
generator, single-patient-use disposable antennas, and a
thermistor-based temperature monitoring system. The innovative
design of the MicroThermX is the first of its kind that allows
delivery of higher power levels using a single generator. The
MicroThermX utilizes innovative synchronous phased array technology
that was developed and patented by BSD to provide larger and more
uniform zones of ablation during a single procedure. The
MicroThermX product line includes an innovative, high-end
disposable that is used in each ablation treatment, and provides
ongoing revenue streams for BSD. The soft tissue ablation world
market potential is estimated to exceed $2.3 billion. The U.S. Food
and Drug Administration (FDA) has granted the Company a 510(k)
clearance to market the MicroThermX for ablation of soft tissue.
BSD has also received CE Marking for the MicroThermX System, which
allows BSD to market the MicroThermX system in Europe. CE marking
is also recognized in many countries outside of the EU, providing
BSD the ability to market the MicroThermX to a number of
international markets.
About BSD Medical Corporation
BSD Medical Corporation develops, manufactures, markets and
services systems to treat cancer and benign diseases using heat
therapy, which is delivered using focused radiofrequency (RF) and
microwave energy. BSD’s product lines include both hyperthermia and
ablation treatment systems. BSD’s MicroThermX microwave ablation
system has been developed as a stand-alone therapy to employ
precision-guided microwave energy to ablate (destroy) soft tissue.
The Company has developed extensive intellectual property, multiple
products in the market and established distribution in the United
States, Europe and Asia. Certain of the Company’s products have
received regulatory approvals and clearances in the United States,
Europe and China. For further information visit BSD Medical's
website at www.BSDMedical.com.
This press release may be deemed to contain forward-looking
statements, which are subject to the safe harbor provisions of the
Private Securities Litigation Reform Act of 1995. Readers are
cautioned that these forward-looking statements are only
predictions and may differ materially from actual future events or
results due to a variety of factors, including, among other things,
the demand for the Company’s products, the ability of the Company
to produce the products to meet the demand, global economic
conditions and uncertainties in the geopolitical environment and
other risk factors set forth in the Company’s most recent reports
on Form 10-K and Form 10-Q. Any forward-looking statements in this
release are based on limited information currently available to the
Company, which is subject to change, and the Company will not
necessarily update the information.
Financial ProfilesTricia Ross,
310-622-8226tross@finprofiles.com